Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.09 -0.03 (-2.68%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) EBIT (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) recorded EBIT of -$3.34 million in Q2 2026, compared with -$3.73 million a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) EBIT (2022 - 2026) Analysis & Trends

On a TTM basis, Cadrenal Therapeutics' EBIT came in at -$12 million as of Jun 30, 2026; for FY2023, it was -$7.63 million.

  • Across earlier years, EBIT came in at -$2.7 million in FY2022.
  • The Q2 2026 figure is the highest quarterly EBIT since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Cadrenal Therapeutics 3.47 Mn -9.15 Mn - -3.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.34 Mn
Jun 30, 2025 -3.73 Mn
Sep 30, 2024 -2.46 Mn
Jun 30, 2024 -2.47 Mn
Mar 31, 2024 -1.76 Mn
Dec 31, 2023 -1.26 Mn
Sep 30, 2023 -1.14 Mn
Jun 30, 2023 -1.03 Mn
Mar 31, 2023 -4.20 Mn
Dec 31, 2022 -1.08 Mn
Sep 30, 2022 -972,791.00
Jun 30, 2022 -482,347.00
Mar 31, 2022 -170,521.00
API Access

Cadrenal Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=CVKD&period=max&api_key=YOUR_API_KEY